ImmunityBio Inc (NASDAQ: IBRX) is -46.81% lower on its value in year-to-date trading and has touched a low of $2.61 and a high of $10.53 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IBRX stock was last observed hovering at around $2.62 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $2.67, the stock is -32.49% and -39.88% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.68 million and changing 1.91% at the moment leaves the stock -48.67% off its SMA200. IBRX registered -34.56% loss for a year compared to 6-month loss of -63.27%. The firm has a 50-day simple moving average (SMA 50) of $4.4606 and a 200-day simple moving average (SMA200) of $5.216025.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -46.97% gain in the last 1 month and extending the period to 3 months gives it a -25.83%, and is -12.75% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.30% over the week and 7.41% over the month.
ImmunityBio Inc (IBRX) has around 628 employees, a market worth around $1.95B and $7.33M in sales. Profit margin for the company is -8016.83%. Distance from 52-week low is 2.30% and -74.64% from its 52-week high. The company has generated returns on investments over the last 12 months (-222.32%).
with sales reaching $9.07M over the same period.The EPS is expected to grow by 27.54% this year, but quarterly earnings will post 3,745.87% year-over-year. Quarterly sales are estimated to grow 6,425.90% in year-over-year returns.
ImmunityBio Inc (IBRX) Top Institutional Holders
254.0 institutions hold shares in ImmunityBio Inc (IBRX), with institutional investors hold 36.37% of the company’s shares. The shares outstanding are 696.83M, and float is at 44.67M with Short Float at 111.44%. Institutions hold 9.64% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 13.83 million shares valued at $87.42 million. The investor’s holdings represent 2.0558% of the IBRX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 11.42 million shares valued at $72.19 million to account for 1.6978 of the shares outstanding. The other top investors are STATE STREET CORP which holds 7.86 million shares representing 1.1688% and valued at over $49.7 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.5822 of the shares totaling 3.92 million with a market value of $24.76 million.
ImmunityBio Inc (IBRX) Insider Activity
#####
